Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mindset Pharma (MSET) stocks in Canada

Learn how to easily invest in Mindset Pharma stocks.

Mindset Pharma is a biotechnology business based in Canada. Mindset Pharma stocks (MSET.CN) are listed on the CN and all prices are listed in Canadian Dollars. Its last market close was C$0.475 – a decrease of 20.22% over the previous week. Mindset Pharma employs 0 staff and has a market cap (total outstanding stock value) of C$78.2 million.

How to buy shares in Mindset Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MSET – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Mindset Pharma stock price (CN:MSET)

Use our graph to track the performance of MSET stocks over time.

Mindset Pharma shares at a glance

Information last updated 2022-01-17.
Latest market closeC$0.71
52-week rangeC$0.33 - C$1.55
50-day moving average C$0.73
200-day moving average C$1.52
Wall St. target priceC$5.07
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) C$-0.22

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Mindset Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Mindset Pharma price performance over time

Historical closes compared with the close of C$0.71 from 2022-01-20

1 week (2022-01-14) -20.22%
1 month (2021-12-21) 7.58%
3 months (2021-10-21) -4.05%
6 months (2021-07-21) 39.22%
1 year (2021-01-21) -21.11%
2 years (2020-01-17) N/A
3 years (2019-01-17) N/A
5 years (2017-01-17) N/A

Mindset Pharma financials

Gross profit TTM C$0
Return on assets TTM -78.77%
Return on equity TTM -245.62%
Profit margin 0%
Book value C$0.07
Market capitalisation C$78.2 million

TTM: trailing 12 months

Mindset Pharma share dividends

We're not expecting Mindset Pharma to pay a dividend over the next 12 months.

Mindset Pharma overview

Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company was founded in 2019 and is based in Toronto, Canada. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site